.svg){kind=icon}
Accelerating development does not have to mean accepting more risk. The key is identifying risks earlier, while there is still time to address them. Predictive Clinical Development helps sponsors anticipate recruitment, operational, and execution challenges before they become delays, enabling faster decisions, more predictable execution, and accelerated timelines without compromising quality.
Accelerate with confidence and speed
Predictive Clinical Development helps sponsors identify risks before execution begins and make better decisions at every stage of development. By combining AI enabled workflows, real world evidence, and operational expertise, IQVIA helps teams reduce uncertainty, prevent avoidable delays, and move programs forward with greater confidence.
Save up to two years off a ten-year program with Predictive Clinical Development
Predictive Clinical Development
One connected approach
Prevent delays before they happen
Many development challenges begin long before a protocol is finalized. Early decisions about trial design, patient populations, and site strategy can have lasting implications for timelines and execution.
By combining real world evidence, therapeutic expertise, and regulatory insight, IQVIA helps sponsors make more informed decisions earlier. The result is a development strategy that is more predictable and better positioned for success.
- Replace assumptions with evidence-based planning.
- Reduce rework through continuous decision support.
Predictive Clinical Development improves confidence before critical development decisions are locked in.
Accelerate trial start-up by eliminating down time
Many start-up delays are not caused by the work itself, but because traditional, sequential approaches create unnecessary bottlenecks.
IQVIA compresses timelines by advancing key activities in parallel across clinical operations, lab and data management.
By reducing delays between protocol finalization and patient enrollment, sponsors can move trials forward faster.
The result: 33% faster study start-up vs IQVIA historical performance.
Accelerate patient recruitment and trial execution
Patient recruitment remains one of the most significant drivers of clinical trial delays. Identifying the right patients, selecting high-performing sites, and responding quickly to emerging challenges are critical to keeping trials on track.
IQVIA combines predictive enrollment analytics, digital patient engagement, site networks, and operational expertise to help sponsors recruit more effectively and maintain momentum throughout trial execution.
The result: 42% higher enrollment rates for IQVIA’s top tier sites vs other sites.
Turn clinical trial data into faster decisions
Issues are often identified too late when clinical, operational, and laboratory data are reviewed in separate cycles. The result is rework at database lock and delays to trial completion.
IQVIA brings transparency with a continuous view of trial data, using Healthcare-grade AI® to surface issues earlier and support faster resolution.
With Predictive Clinical Development, teams work from the same data foundation, helping trials reach closeout with fewer delays and greater submission readiness.
The result: 50% faster data cleaning vs historical performance.
IQVIA can reduce up to two years of a ten-year program
Sponsors who plan at the program level recover time that trial-by-trial optimization can never reach.
By reducing delays between phases and enabling earlier decision-making, IQVIA helps sponsors accelerate development programs and bring new therapies to patients up to two years faster across a typical 10-year development program.
Power more predictable, accelerated clinical development
Why Predictive Clinical Development?
Predict Risks Earlier
Identify operational, recruitment, and protocol risks before execution begins.
Prevent Trial Delays
Reduce rework and eliminate execution bottlenecks.
Accelerate Clinical Development
Improve speed and predictability across the development lifecycle.
Predictive Clinical Development FAQs
Clinical trial delay prevention starts before the protocol is final, because feasibility, recruitment and operational risks are far easier to resolve in planning than in the field. IQVIA applies predictive analytics and real world evidence during planning so sponsors can see which assumptions are likely to hold.
Learn more about clinical trial risk prediction and planning.
Clinical trial predictability improves when the assumptions behind a protocol are tested against evidence of how similar trials actually performed, rather than against expectation. IQVIA draws on data from thousands of completed studies to show sponsors what enrollment, site performance and timelines have really looked like for comparable programs.
Real world evidence answers questions about patients and feasibility using what has already happened in routine care, so sponsors are not waiting on a study to learn something the data can tell them now. IQVIA applies that evidence from early planning onward, which lets decisions be made sooner and with less guesswork.
Recruitment and site performance improve when site selection reflects where eligible patients actually are and how those sites have enrolled before. IQVIA pairs predictive recruitment insight with established site networks so enrollment plans are built on demonstrated performance.
Clinical trials run more efficiently when data flows continuously across teams, systems, and stages of development. IQVIA connects data streams across the clinical ecosystem, providing real-time visibility into study performance and helping sponsors identify, prioritize, and resolve issues earlier. This continuous flow of information supports faster decisions and more efficient execution.
Early phase work determines how efficiently everything after it progresses, because the dose, population and endpoint decisions made there carry through to Phase III. IQVIA supports those decisions with evidence rather than convention, so later phases start from firmer ground.
Laboratory testing is only as valuable as the speed at which results become actionable. IQVIA creates a continuous flow of laboratory data and insights, helping study teams make faster decisions and keep trials moving forward.